# Impact of Varying Resuscitation Proportions of Resuscitated Patients on VA-ECMO Outcomes in the ECLS-SHOCK Trial

**Authors:** Tharusan Thevathasan, Uwe Zeymer, Anne Freund, Janine Pöss, Steffen Schneider, Holger Thiele, Steffen Desch

PMC · DOI: 10.1016/j.jacadv.2026.102585 · JACC: Advances · 2026-01-29

## Full-text entities

- **Genes:** POR (cytochrome p450 oxidoreductase) [NCBI Gene 5447] {aka CPR, CYPOR, P450R}
- **Diseases:** CS (MESH:D006223), SHOCK (MESH:D012769), acute myocardial infarction (MESH:D009203), left ventricular failure (MESH:D051437), Cardiogenic Shock (MESH:D012770)
- **Chemicals:** VA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12874812/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12874812/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12874812/full.md

---
Source: https://tomesphere.com/paper/PMC12874812